One of the nation’s most interesting, patient- and media-friendly medical organizations next week will focus on a topic more relevant than ever during a pandemic. The annual meeting of the Society to Improve Diagnosis in Medicine (SIDM), which starts Monday as a virtual event, will focus on “Transforming Education and Practice to Improve Diagnosis.” Continue reading
With public trust at an all-time low in government scientists and public health agencies, what can be done to repair confidence in the U.S. Centers for Disease Control and Prevention, with an eye toward preparing for the next pandemic?
Though it may seem too early to be thinking about another pandemic, the Council on Foreign Relations (CFR), a New York-based non-partisan think tank is doing just that. On Oct. 8, the CFR issued a report – “Improving Pandemic Preparedness: Lessons from COVID-19” – to provide a roadmap for getting the U.S. out of the pandemic and respond to the next one. Continue reading
A new partnership will provide free training and mentorship to nursing homes across the country to improve evidence-based infection prevention and safety practices.
The National Nursing Home COVID Action Network is a collaboration by the Agency for Healthcare Research and Quality (AHRQ), the University of New Mexico’s ECHO Institute in Albuquerque and the Institute for Healthcare Improvement (IHI) in Boston. The goal is to further protect residents and staff from the SARS-COV-2 virus. Continue reading
Francis Collins, director of the National Institutes of Health, will be a featured speaker at the Association of Health Care Journalists’ Summit on Infectious Disease next month.
AHCJ has recruited experts and leading health care journalists to discuss data resources, treatments and vaccine development, health workers and vulnerable populations, COVID-19 and influenza sharing a season. Continue reading
The timeless advice sometimes attributed to Deep Throat or Bob Woodard and Carl Bernstein to “follow the money” certainly applies to COVID-19.
For reporters looking for local stories, follow the money doled out by the National Institutes of Health for COVID-19 research. Most recently, the National Cancer Institute, which received $306 million from Congress through the Coronavirus Aid, Relief, and Economic Security Act, announced the first grants and contracts to researchers to form the Serological Sciences Network for COVID-19. Continue reading
In a previous blog post, I discussed what reporters look for when they dig into the data from the various COVID-19 vaccine clinical trials. That post covered the do’s, but it didn’t cover the red flags that reporters should watch for as well.
Vinay Prasad, M.D., a hematologist-oncologist and associate professor of medicine at the University of California, San Francisco, followed up his Twitter thread on what to look for with a list of common problems in vaccine clinical trials that journalists also should monitor: Continue reading